Real-time enrollment status for this endometrial neoplasms clinical trial
Current Status
Recruiting
Checked: October 30, 2026 at 10:12 PM UTC
| NCT Number | NCT07578649 |
| Recruiting Status | Recruiting |
| Condition | Endometrial Neoplasms |
| Phase | PHASE3 |
| Target Enrollment | 600 participants |
| Active Locations | 42 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | October 30, 2026 (22 hours ago) |
As of October 30, 2026: Clinical trial NCT07578649 is currently recruiting participants. This phase3 study for endometrial neoplasms is actively seeking new participants at 42 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07578649 is actively recruiting participants as of October 30, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 42 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07578649 was last updated 22 hours ago (October 30, 2026). HelloStudys verifies this status automatically.